Gemtesa (vibegron) is a prescription drug that’s used in adults to treat an overactive bladder. Gemtesa’s cost may depend on factors such as your dosage, whether you have health insurance, and the pharmacy you use.

Gemtesa comes as an oral tablet. It contains the active ingredient vibegron. (An active ingredient is what makes a drug work.)

For more details on Gemtesa, see this in-depth article.

The price you pay for Gemtesa can vary. It may depend on your treatment plan, your insurance coverage (if you have it), and the pharmacy you use.

To find out how much you’ll pay for Gemtesa, talk with your doctor, pharmacist, or insurance provider.

Note: If you have insurance, you may need to get prior authorization before your insurance provider will cover Gemtesa. This means your insurer and your doctor will discuss Gemtesa in regard to your treatment. Then the insurance company will determine whether the drug is covered. If Gemtesa requires prior authorization and you don’t receive it before you start treatment, you could pay the full cost of the drug.

Be sure to ask your insurance company whether Gemtesa requires prior authorization.

Gemtesa only comes as a brand-name drug. It’s not currently available in a generic version. A generic contains an exact copy of the active drug in a brand-name medication but tends to cost less.

Why is there such a cost difference between brand-name drugs and generics?

Years of research and testing are needed to ensure that brand-name drugs are safe and effective. This testing can make the drugs expensive. The manufacturer of a brand-name drug can sell the drug for up to 20 years. After that, other drugmakers can create generic versions. This competition in the market can lead to lower costs for generics. And because generics have the same active ingredients as brand-name drugs, they don’t need to be studied again. This can also lead to lower generic costs.

If you take Gemtesa long term, you may be able to lower your costs in the following ways:

Look into getting a 90-day supply of your medication. You may be able to get a 90-day supply of Gemtesa if approved by your insurance company. This could reduce your number of trips to the pharmacy and help lower the cost of Gemtesa. If you’re interested in getting a 90-day supply of this drug, talk with your doctor, pharmacist, or insurance provider.

Use a mail-order pharmacy to get your medication. Using a mail-order pharmacy might help lower your cost for Gemtesa. Plus, you could get your medication without leaving home. Some Medicare plans may help cover the cost of mail-order drugs. You may also be able to get a 90-day supply of the drug through mail order. If you don’t have health insurance, talk with your doctor or pharmacist. They may be able to suggest online pharmacy options that could work for you.

If you need help covering the cost of Gemtesa or understanding your insurance, check out these resources:

On these sites, you can find insurance information, details on drug assistance programs, and links to savings cards and other services.

If you have questions about how to pay for your prescription, talk with your doctor or pharmacist.

Below are answers to some frequently asked questions about Gemtesa and cost.

How does the cost of Gemtesa compare with that of similar drugs, such as Myrbetriq?

The cost of Gemtesa compared with the cost of Myrbetriq can depend on several factors.

For example, Gemtesa comes in a different form than Myrbetriq, which may affect the cost. Gemtesa is an oral tablet, while Myrbetriq comes as an extended-release tablet and as granules to mix into a liquid solution you drink.

Other factors that may affect how much you pay include:

  • whether there are any coupon cost savings programs available for the drug you’re prescribed
  • whether you have insurance or are paying out of pocket
  • how long your treatment lasts

If you have questions about the cost of Gemtesa compared with that of similar medications, talk with your doctor, pharmacist, or insurance provider. They can share more details on treatment costs based on your specific situation.

Is Gemtesa covered by Medicare?

It’s possible. To find out whether your Medicare plan covers the cost of Gemtesa, call your plan provider. There are many different types of Medicare plans available, and your cost and coverage depend on your individual plan benefits.

Keep in mind that your plan may have prior authorization requirements before it will cover Gemtesa.

You can also ask your doctor about the cost of Gemtesa if you have Medicare.

If you still have questions about the cost of Gemtesa, talk with your doctor or pharmacist. They may be able to give you a better idea of what you’ll pay for this drug. But if you have health insurance, you’ll need to talk with your insurance provider to learn the actual cost you’d pay for Gemtesa.

Examples of questions you may want to ask your doctor or insurance provider include:

  • If I can’t afford Gemtesa, will my overactive bladder get worse?
  • Can I take a lower dose of Gemtesa to reduce my cost?
  • Is it possible to lower the price of Gemtesa by getting a 90-day supply?

To learn more about Gemtesa, see these articles:

To get information on different conditions and tips for improving your health, subscribe to any of Healthline’s newsletters. You may also want to check out the online communities at Bezzy. It’s a place where people with certain conditions can find support and connect with others.

Disclaimer: Healthline has made every effort to make certain that all information is factually correct, comprehensive, and up to date. However, this article should not be used as a substitute for the knowledge and expertise of a licensed healthcare professional. You should always consult your doctor or another healthcare professional before taking any medication. The drug information contained herein is subject to change and is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or appropriate for all patients or all specific uses.